Mantle Cell Lymphoma | Tumor

CURE’s mantle cell lymphoma (MCL) page features the latest cancer news and updates on mantle cell lymphoma Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in mantle cell lymphoma.

Managing Mantle Cell Lymphoma (MCL) after Relapsed on First Treatment

An interview with Dr. Luhua (Michael) Wang, MD, Department of Lymphoma and Myeloma, Division of Cancer Medicine, MD Anderson Cancer Center

Keep Inspiring

Don’t let your disease define you

Novel Agents May Lead to a Chemo-Free Future for Patients With Mantle Cell Lymphoma

September 6th 2019, 12:00am

Article

One expert discusses the current treatment options for patients with mantle cell lymphoma as well as the potential shift away from chemotherapy in the future.

Study Unveils Family Risk for Certain Types of Blood Cancer

August 14th 2019, 6:00pm

Article

Those with a first-degree relative diagnosed with certain blood cancers may be at an increased risk for developing the disease themselves.

Study Highlights Need for Frailty Testing Among Older Adults with Blood Cancer

August 5th 2019, 5:35pm

Article

A slower walking pace among older adults with blood cancer can be a sign of frailty – which could be useful to know when tailoring one’s care to increase survival and lower hospitalizations.

Cell Therapies May Help Overcome Drug Resistance in Patients With Mantle Cell Lymphoma

July 1st 2019, 7:00pm

Video

Breakthroughs such as CAR-T cell therapy in the treatment of mantle cell lymphoma could help patients overcome drug resistance and ultimately live longer, according to Dr. Michael Wang.

Patients With Mantle Cell Lymphoma Experience Response to Imbruvica Combinations

June 27th 2019, 7:50pm

Article

Newer treatments for MCL offer hope to patients living with the fast-growing and challenging-to-treat disease.

Targeted Therapies for Advanced MCL May Improve Outcomes as Front-line Treatment

June 26th 2019, 8:00pm

Video

Mantle cell lymphoma remains incurable, despite researchers’ best efforts. However, new treatment options show promise in the relapsed/refractory setting and may improve patient outcomes if moved to the front-line, according to Dr. Reem Karmali.

Emergence of Treatment Options in Mantle Cell Lymphoma Excites Many

June 13th 2019, 8:39pm

Article

An expert discusses the exciting approaches under investigation in mantle cell lymphoma and insight into where future research should focus.

Imbruvica Shows Promise as Maintenance Therapy for Patients With MCL

June 13th 2019, 5:00pm

Video

Maintenance therapy with Imbruvica appeared to be a feasible option for patients with mantle cell lymphoma, according to Dr. Reem Karmali.

CAR-T Cell Therapy Shows Potential in Relapsed/Refractory Mantle Cell Lymphoma

June 12th 2019, 7:00pm

Article

Treatment with lisocabtagene maraleucel, also known as liso-cel, demonstrated clinical activity and appeared tolerable among patients with relapsed/refractory mantle cell lymphoma.

Researcher Highlights the Need for Curative Approach to Mantle Cell Lymphoma Treatment

May 20th 2019, 7:06pm

Article

While many advances have been made in the treatment landscape of MCL, the need for curative treatment options may be where future research goes.